About Matt Rightmire

This author has not yet filled in any details.
So far Matt Rightmire has created 68 blog entries.

FierceBiotech Names Compass Therapeutics a 2018 “Fierce 15” Biotech Company

Compass Therapeutics, a biotechnology company committed to the ambitious goal of comprehensively drugging the human immune system, today announced that it has been named by FierceBiotech as one of 2018’s Fierce 15 biotechnology companies, designating it as one of the most promising private biotech companies in the industry. Compass, which completed its $132 million Series [...]

By | October 2nd, 2018|Dartmouth Innovation, News|

Vets First Choice Wins Approval to Build New Headquarters in Downtown Portland

Vets First Choice has received city approval to commence construction of a new headquarters in Portland, Maine to support its rapid growth and expansion. The new approximately 170,000 square foot facility will support more than 1,500 employees, including a state-of-the-art pharmacy facility, enhanced software and data science labs, and office space. “We’re thrilled to announce [...]

By | September 26th, 2018|Dartmouth Innovation, News|

Evox Therapeutics completes £35 million Series B financing

Evox Therapeutics Ltd (‘Evox’ or the ‘Company’), a leading exosome therapeutics company, today announces that it has raised £35.5 million ($45.4 million) of new capital in a Series B financing round. Redmile Group led the financing with significant new investments from GV (formerly Google Ventures) and Cowen Healthcare Investments, alongside investments from Panacea Healthcare Venture, [...]

By | September 3rd, 2018|Dartmouth Innovation, News|

Compass Therapeutics Completes $132 Million Series A Financing to Advance Next-generation Antibody-based Therapeutics into the Clinic

Compass Therapeutics, a biotechnology company committed to the ambitious goal of comprehensively drugging the human immune system, today announced the closing of the final $49 million of its $132 million Series A financing. This financing will enable the company to advance its next-generation antibody-based therapeutics into the clinic. The financing was led by OrbiMed Advisors [...]

By | July 12th, 2018|Dartmouth Innovation, New Hampshire, News|

Autodesk acquires Assemble Systems to build up its construction tech vertical

Autodesk has made a name for itself among designers, engineers and architects with its 3D and other modelling software. Now, as it continues to build out its business in adjacent business areas like construction, it has acquired Assemble Systems, a startup that has built a platform to help plan and run building projects — and [...]

By | July 9th, 2018|Design & Engineering Software, News|

Peptide Display Company Orbit Discovery Closes £6.9M Series A Financing

Orbit Discovery Ltd, an Oxford, UK-based biotech company developing an industry-leading peptide identification and optimisation platform, today announced the closing of a £6.9M Series A Financing. The round was led by Oxford Sciences Innovation who were joined by new investors RT Ventures, Borealis Ventures, Perivoli Innovations, along with further investment from all existing investors and [...]

By | May 23rd, 2018|Dartmouth Innovation, News|

Vets First Choice To Merge With Henry Schein Animal Health

Henry Schein, Inc. (Nasdaq: HSIC) and Vets First Choice announced plans today for Henry Schein to spin off its Animal Health business and merge it with Vets First Choice, creating an innovative approach to advancing the delivery of animal health care designed to provide unique benefits to veterinarians, manufacturers, pet owners, and their pets. The [...]

By | April 23rd, 2018|News|

Adimab Announces Antibody Discovery Collaboration with Boehringer Ingelheim

Adimab, LLC, the global leader in the discovery and optimization of fully human monoclonal and bispecific antibodies, today announced a multi-target partnership with Boehringer Ingelheim (BI). Under the terms of the agreement, Adimab will use its proprietary platform to discover and optimize antibodies against targets chosen by BI, who will have the rights to develop [...]

By | January 10th, 2018|Dartmouth Innovation|

Adimab Provides Year-End Update on 2017 Partnership Activities

Adimab, LLC, the global leader in the discovery and optimization of fully human monoclonal and bispecific antibodies, today announced that in 2017 it entered into agreements with seven new companies. In addition, Adimab announced the expansion of 12 of its current partnerships and the achievement of 49 technical and development milestones across multiple collaborations. Read [...]

By | January 8th, 2018|Dartmouth Innovation, New Hampshire, News|

Paul Allen’s Vulcan backs ex-Amazon manager’s modular housing startup Blokable in $4.8M round

Investors are taking note of Blokable, a Seattle startup founded by a former Amazon manager that aims to cut costs for builders and residents alike through the construction of tech-powered manufactured housing. The company’s single- and multifamily housing will be made of modular units ranging in length from 18 feet to 38 feet that can [...]

By | September 15th, 2017|Design & Engineering Software, News|